Mucin-type fusion proteins with blood group A or B determinants on defined O-glycan core chains produced in glycoengineered Chinese hamster ovary cells and their use as immunoaffinity matrices

Glycobiology

Volumn 23, Issue 6, 2013, Pages 720-735

  Lindberg, Linda ^a   Liu, Jining ^a   Gaunitz, Stefan ^b   Nilsson, Anki ^c   Johansson, Tomas ^c   Karlsson, Niclas G ^d   Holgersson, Jan ^e  

^a AbSorber   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Recopharma AB   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

blood group ABH antigens; glycoengineering; immunoadsorption; mucins

Indexed keywords

CARBOHYDRATE DERIVATIVE; COMPLEMENTARY DNA; GLYCAN; HYBRID PROTEIN; IMMUNOGLOBULIN G2B; MUCIN; P SELECTIN GLYCOPROTEIN LIGAND 1;

ANIMAL CELL; ANTIBODY AFFINITY; ARTICLE; BIOREACTOR; BIOTRANSFORMATION; BLOOD GROUP A; BLOOD GROUP B; CELL ENGINEERING; CHO CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL IMMUNOADSORPTION; FEMALE; FUCOSYLATION; GENETIC TRANSFECTION; IMMUNOADSORPTION; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALYLATION;

BLOOD GROUP ABH ANTIGENS; GLYCOENGINEERING; IMMUNOADSORPTION; MUCINS;

ABO BLOOD-GROUP SYSTEM; ANIMALS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CHO CELLS; CHROMATOGRAPHY, AFFINITY; CRICETULUS; GLYCOSYLATION; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUCINS; N-ACETYLGALACTOSAMINYLTRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS;

EID: 84877278696     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt011     Document Type: Article

References (46)

1. Abe K, Levery SB, Hakomori S. 1984. The antibody specific to type 1 chain blood group A determinant. J Immunol. 132:1951-1954.
2. Amado M, Almeida R, Schwientek T, Clausen H. 1999. Identification and characterization of large galactosyltransferase gene families: Galactosyltransferases for all functions. Biochim Biophys Acta. 1473:35-53.
3. Ceroni A, Dell A, Haslam SM. 2007. The GlycanBuilder: A fast, intuitive and flexible software tool for building and displaying glycan structures. Source Code Biol Med. 2:3.
4. Ceroni A, Maass K, Geyer H, Geyer R, Dell A, Haslam SM. 2008. GlycoWorkbench: A tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res. 7:1650-1659.
5. Clausen H, Hakomori S. 1989. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang. 56:1-20.
6. Clausen H, Levery SB, Nudelman E, Baldwin M, Hakomori S. 1986. Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes. Biochemistry. 25:7075-7085.
7. Clausen H, Levery SB, Nudelman E, Tsuchiya S, Hakomori S. 1985. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: Chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci USA. 82:1199-1203.
8. Coombs PJ, Harrison R, Pemberton S, Quintero-Martinez A, Parry S, Haslam SM, Dell A, Taylor ME, Drickamer K. 2010. Identification of novel contributions to high-affinity glycoprotein-receptor interactions using engineered ligands. J Mol Biol. 396:685-696.
9. Genberg H, Kumlien G, Wennberg L, Berg U, Tyden G. 2008. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation. 85:1745-1754.
10. Gustafsson A, Holgersson J. 2006. A new generation of carbohydrate-based therapeutics: Recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions. Expert Opin Drug Discovery. 1:161-178.
11. Gustafsson A, Sjöblom M, Strindelius L, Johansson T, Fleckenstein T, Chatzissavidou N, Lindberg L, Ångström J, Rova U, Holgersson J. 2011. Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system. Glycobiology. 21:1071-1086.
12. Hayes CA, Karlsson NG, Struwe WB, Lisacek F, Rudd PM, Packer NH, Campbell MP. 2011. UniCarb-DB: A database resource for glycomic discovery. Bioinformatics. 27:1343-1344.
13. Hennet T. 2002. The galactosyltransferase family. Cell Mol Life Sci. 59:1081-1095.
14. Holgersson J, Breimer ME, Samuelsson BE. 1992. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histoblood group ABH and related glycosphingolipids. APMIS Suppl. 27:18-27.
15. Holgersson J, Gustafsson A, Breimer ME. 2005. Characteristics of proteincarbohydrate interactions as a basis for developing novel carbohydratebased antirejection therapies. Immunol Cell Biol. 83:694-708.
16. Holgersson J, Lofling J. 2006. Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity. Glycobiology. 16:584-593.
17. Jensen PH, Kolarich D, Packer NH. 2010. Mucin-type O-glycosylation- putting the pieces together. FEBS J. 277:81-94.
18. Ju T, Brewer K, D'Souza A, Cummings RD, Canfield WM. 2002. Cloning and expression of human core 1 β1,3galactosyltransferase. J Biol Chem. 277:178-186.
19. Karlsson NG, Schulz BL, Packer NH. 2004. Structural determination of neutral O-linked oligosaccharide alditols by negative ion LC-electrospray-MSn. J Am Soc Mass Spectrom. 15:659-672.
20. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. 1995. Sequence and expression of a candidate for the human Secretor blood group alpha(1,2) fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem. 270:4640-4649.
21. Kumlien G, Ullstrom L, Losvall A, Persson L-G, Tyden G. 2006. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion. 46:1568-1575.
22. Larsen RD, Ernst LK, Nair RP, Lowe JB. 1990. Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L- fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA. 87:6674-6678.
23. Lindberg L, Johansson SM, Liu J, Grufman P, Holgersson J. 2011. Is there a clinical need for a diagnostic test allowing detection of chain type-specific anti-A and anti-B Transfusion. 51:494-503.
24. Lindberg L, Liu J, Holgersson J 2013. Engineering of therapeutic and diagnostic O-glycans on recombinant mucin-type immunoglobulin fusion proteins expressed in CHO cells. In: Beck A, editor. Glycosylation Engineering of Biopharmaceuticals, Methods Mol Biol. (N.Y) Vol. 988. New York (USA): Humana Press.
25. Lindberg L, Theinert K, Liu J, Holgersson J. 2012. Adsorption of chain typespecific ABO antibodies on Sepharose-linked A and B tetrasaccharides. Transfusion. 52:2356-67.
26. Liu J, Gustafsson A, Breimer ME, Kussak A, Holgersson J. 2005. Anti-pig antibody adsorption efficacy of α-Gal carrying recombinant P-selectin glycoprotein ligand-1/immunoglobulin chimeras increases with core 2 {β1, 6-N-acetylglucosaminyltransferase expression. Glycobiology. 15:571-583.
27. Liu J, Qian Y, Holgersson J. 1997. Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope. Transplantation. 63: 1673-1682.
28. Lofling J, Diswall M, Eriksson S, Boren T, Breimer ME, Holgersson J. 2008. Studies of Lewis antigens and H. pylori adhesion in CHO cell lines engineered to express Lewis b determinants. Glycobiology. 18:494-501.
29. Lofling JC, Hauzenberger E, Holgersson J. 2002. Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood group A determinants: Core saccharide chain specificity of the Se and H gene encoded alpha1,2 fucosyltransferases in different host cells. Glycobiology. 12:173-182.
30. Lofling J, Holgersson J. 2009. Core saccharide dependence of sialyl Lewis X biosynthesis. Glycoconj J. 26:33-40.
31. Ly M, Laremore TN, Linhardt RJ. 2010. Proteoglycomics: Recent progress and future challenges. OMICS. 14:389-399.
32. Mammen M, Choi S, Whitesides G. 1998. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed. 37:2754-2794.
33. Meloncelli PJ, Lowary TL. 2009. Synthesis of ABO histo-blood group type Vand VI antigens. Aust J Chem. 62:558-574.
34. Meloncelli PJ, Lowary TL. 2010. Synthesis of ABO histo-blood group type I and II antigens. Carbohydr Res. 345:2305-2322.
35. Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D. 1995. Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem. 270:4632-4639.
36. Rydberg L, Breimer ME, Holgersson J, Karlsson KA, Nyholm PG, Pascher I, Svensson L, Samuelsson BE. 1992. Characterisation of the anti-A antibody response following an ABO incompatible (A2 to O) kidney transplantation. Mol Immunol. 29:547-560.
37. Rydberg L, Nyberg G, Attman PO, Mjornstedt L, Tufveson G, Blohme I. 1994. Characterization of the anti-A antibody binding in an ABO-incompatible living donor renal transplantation. Nephrol Dial Transplant. 9:1162-1165.
38. Stanley P, Siminovitch L. 1977. Complementation between mutants of CHO cells resistant to a variety of plant lectins. Somatic Cell Genet. 3:391-405.
39. Storry JR, Olsson ML. 2009. The ABO blood group system revisited: A review and update. Immunohematology. 25:48-59.
40. Tian E, Ten Hagen KG. 2009. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J. 26:325-334.
41. Togayachi A, Sato T, Narimatsu H. 2006. Comprehensive enzymatic characterization of glycosyltranferases with a β3GT or β4GT motif. Methods Enzymol. 416:91-101.
42. Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I. 2005. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant. 5:145-148.
43. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. 1990. Molecular genetic basis of the histo-blood group ABO system. Nature. 345:229-233.
44. Yang Z, Bergstrom J, Karlsson KA. 1994. Glycoproteins with Gal alpha 4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities. J Biol Chem. 269:14620-14624.
45. Yeh JC, Hiraoka N, Petryniak B, Nakayama J, Ellies LG, Rabuka D, Hindsgaul O, Marth JD, Lowe JB, Fukuda M. 2001. Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N- acetylglucosaminyltransferase. Cell. 105:957-969.
46. Zhou D, Henion T, Jungalwala FB, Berger EG, Hennet T. 2000. The β1,3-galactosyltransferase β3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase. J Biol Chem. 275:22631-22634.